The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia. [electronic resource]
Producer: 20071127Description: 584-93 p. digitalISSN:- 1083-7159
- Activities of Daily Living
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Anemia -- blood
- Antineoplastic Agents -- adverse effects
- Biomarkers -- blood
- Darbepoetin alfa
- Drug Administration Schedule
- Erythrocyte Transfusion
- Erythropoietin -- administration & dosage
- Fatigue -- chemically induced
- Female
- Follow-Up Studies
- Hematinics -- administration & dosage
- Hemoglobins -- drug effects
- Humans
- Karnofsky Performance Status
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Quality of Life
- Research Design
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.